Winston Pharmaceuticals (WPHM) Price & Analysis

5 Followers

WPHM Stock Chart & Stats

$0.09

>-$0.01(-99.00%)

At close: Apr 29 4:00 PM EDT

$0.09

>-$0.01(-99.00%)

Day’s Range― - ―

52-Week Range$0.09 - $0.29

Previous CloseN/A

Volume125.00

Average Volume (3M)0.00

Market Cap

$77.00

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta13.51

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding77,408,890

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

WPHM FAQ

What was Winston Pharmaceuticals Inc’s price range in the past 12 months?

Winston Pharmaceuticals Inc lowest stock price was $0.09 and its highest was $0.29 in the past 12 months.

What is Winston Pharmaceuticals Inc’s market cap?

Winston Pharmaceuticals Inc’s market cap is $77.00.

When is Winston Pharmaceuticals Inc’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Winston Pharmaceuticals Inc’s earnings last quarter?

Currently, no data Available

Is Winston Pharmaceuticals Inc overvalued?

According to Wall Street analysts Winston Pharmaceuticals Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Winston Pharmaceuticals Inc pay dividends?

Winston Pharmaceuticals Inc does not currently pay dividends.

What is Winston Pharmaceuticals Inc’s EPS estimate?

Winston Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Winston Pharmaceuticals Inc have?

Winston Pharmaceuticals Inc has 77,408,890 shares outstanding.

What happened to Winston Pharmaceuticals Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Winston Pharmaceuticals Inc?

Currently, no hedge funds are holding shares in WPHM

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Winston Pharmaceuticals Inc

Winston Pharmaceuticals, Inc. (WPHM) is a biopharmaceutical firm dedicated to the discovery, development, and market introduction of innovative treatments for pain. The company's pipeline and offerings address a broad spectrum of painful conditions, encompassing episodic cluster headaches, chronic migraines, various neuropathic pain syndromes, and discomfort associated with both osteoarthritis and rheumatoid arthritis. They also tackle pain and inflammation linked to inflammatory bowel disease, alongside other specialized therapeutic areas. The organization, initially established as Winston Laboratories, Inc., adopted its present name, Winston Pharmaceuticals, Inc., in November 2008. Founded in 1998, Winston Pharmaceuticals maintains its principal operations in Vernon Hills, Illinois.